Skin reactions associated with bisphosphonates: a report of 3 cases and an approach to management.
Phillips
E
E
Department of Medicine, Sunnybrook Health Science Center, Toronto, Ontario, Canada.
Knowles
S
S
Weber
E
E
Shear
N H
NH
D000328:Adult; D019386:Alendronate / Q000009:adverse effects; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001943:Breast Neoplasms / Q000150:complications / Q000188:drug therapy; D004002:Clodronic Acid / Q000009:adverse effects; D004164:Diphosphonates / Q000009:adverse effects*; D004342:Drug Hypersensitivity / Q000150:complications* / Q000276:immunology; D012968:Etidronic Acid / Q000009:adverse effects; D005260:Female; D006801:Humans; D008875:Middle Aged; D000077268:Pamidronate; D012882:Skin Tests; D014581:Urticaria / Q000139:chemically induced / Q000150:complications
D000970:Antineoplastic Agents; D004164:Diphosphonates; D004002:Clodronic Acid; D012968:Etidronic Acid; D000077268:Pamidronate; D019386:Alendronate